Effects of Inspiratory Muscle Training (IMT) on Balance Ability and Quality of Life of Diabetes Mellitus Patients

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04947163
Collaborator
(none)
40
1
2
12.5
3.2

Study Details

Study Description

Brief Summary

The disease burden of Diabetes Mellitus (DM) is growing rapidly, and multiple complications have been reported including cardiopulmonary and high fall risk which declines the overall quality of life. IMT can be useful technique to improve the physical and functional performance, reduce the severity of complications and enable the individuals to become active members of community. The current study is intended to evaluate the dual effects of IMT on postural stability and pulmonary function of diabetic patients.

Condition or Disease Intervention/Treatment Phase
  • Device: Inspiratory Muscle Training
  • Device: Sham IMT
N/A

Detailed Description

Diabetes Mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia due to either deficiency of insulin or the inability of the body to utilize it. Hyperglycemia ultimately leads to multiple organ damage in patients with uncontrolled diabetes. The incidence occurs mostly at the age of 55 years equally affecting both genders. The prevalence of diabetes has been increased four times in the last three decades worldwide and global prevalence is increasing alarmingly with about 1 out of every 11 individuals having diabetes mellitus with 90% patients having type 2 diabetes mellitus. The statistical data depicts a huge burden of disease both in morbidity and mortality globally and an anticipated threat on health care system in future. (1) The complications of diabetes have been reported higher in the South Asia region as compared to western counterparts. In Pakistan, according to National Diabetes Survey of Pakistan (NDSP 2016 - 2017), the pooled prevalence of diabetes was projected to be 26.3% affecting 27.4 million people above 20 years of age. These high numbers are directly and indirectly linked with the economic burden on society and ultimately affect the quality of life of diabetics, families, and community.

Clinically, there are different complications (micro & macro vascular) associated with DM and these are main sources of morbidity and mortality. Neuropathy, nephropathy, and retinopathy are the microvascular complications whereas macrovascular complications include cardiovascular diseases, stroke as well as other vascular diseases. Apart from these complications, there are few other complications including decreased resistance to infections, dental issues, birth complications in gestational diabetes, poor balance, sarcopenia and increased risk of fall and fractures. The reduced strength and endurance of diaphragm the vital muscle of respiration lead to compromised respiratory functions.

Peripheral neuropathy, retinopathy and vestibular impairments alter the biomechanical stability and strength of postural control in individuals with DM. The instability generates disparity among muscular and neural structures to execute locomotion abilities, so abnormal gait pattern, weakness in lower limb musculature, impair sensory function, diminished reflexes and high fall risk have been observed.

These musculoskeletal complications compromise the mobility level and impede the performance of functional tasks and Activities of Daily Life (ADLs) in patients with DM. The limited movements and participation restrictions in social activities create inaccessibility and dependence on caregiver has been increased. The overall activity level has been declined and decreases the quality of life of individuals and ultimately developing social and economic burden on community.

Management of DM always emphases to improve the current health status and prevent further complications due to uncontrolled DM. Multiple management approaches have been reported in the literature to maintain adequate glycemic control and manage diabetes related complications and co morbidities. Treatment strategies also focus to maximize the quality of life and minimize the risk of treatment related complications including hypoglycemia. Balance and postural impairments are common in DM due to neuropathic changes and there are different training strategies have been documented in literature to improve postural stability and reduce fall risk. The training approaches include Tai Chi, Wii Fit based training, circuit training, strengthening exercises of lower limbs, gait training and task oriented dynamic training to enhance the overall balance abilities.

The central trunk stability and core strength are integral part of postural stability and balance but there is limited evidence to address these for balance training in DM. There is lacking evidence in literature on specific training targeting the central trunk and core strength to improve the balance ability, reduces fall risk and improve quality of life in DM patients.

Inspiratory Muscle Training (IMT) is a device-based training and widely used therapeutic technique for improving inspiratory muscle strength and endurance, thoracic mobility, exercise capacity, reducing dyspnea and increasing quality of life. Recently, IMT has been used to improve balance and physical performance among elderly.

How IMT is a useful intervention to improve cardiopulmonary function, postural control and quality of life? The underlying mechanism of IMT principal and clinical implications has three-fold mechanisms:

First: Diaphragm thickness and strength enhances balance in two ways. Firstly, there is activation of diaphragm during upper limb movements indicating that the co-activation of diaphragm assists in the mechanical stabilization of the spine. Secondly, it plays a major role in the generation of intra-abdominal pressure which helps in the stabilization of lumbar spine during movements like shoulder abduction and adduction i.e., balance perturbations. These changes will improve the lower limb mobility, quadriceps strength, functional performance, postural control response and exercise tolerance among individuals. It creates an overall impact on enhanced balance strategies, physical performance and postural stability in elderly and other pathological conditions including chronic obstructive pulmonary disease (COPD), cystic fibrosis and stroke.

Second: Increases in diaphragmatic mobility and hypertrophy as well as improved neural control and thickness of respiratory muscles including transversus abdominus and internal obliques leads to increase in exercise capacity, pulmonary function and decreased perceived breathlessness and exertion in the patients. It will increase the strength of respiratory muscles ultimately proving it to be an effective treatment strategy in COPD, chronic heart failure, multiple sclerosis and various respiratory diseases.

Third: IMT exerts certain ergogenic effects through increasing diaphragmatic mobility and strength thereby improving the recovery time in sprinters, limiting cardiac sympathetic hyperactivity in cyclists and enhance rowing performance.

Therefore, it can be hypothesized that IMT is not only effective for improving cardiopulmonary function but is also strongly linked with postural stability. The disease burden of DM is growing rapidly, and multiple complications have been reported including cardiopulmonary and high fall risk which declines the overall quality of life. IMT can be useful technique to improve the physical and functional performance, reduce the severity of complications and enable the individuals to become active members of community. The current study is intended to evaluate the dual effects of IMT on postural stability and pulmonary function of diabetic patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Inspiratory Muscle Training (IMT) on Balance Ability and Quality of Life of Diabetes Mellitus Patients
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jul 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: IMT group

Standard exercise protocol according to ACSM's guidelines Standard exercise protocol according to ACSM's guidelines Balance training - Otago Exercise Program (OEP) warm-up (10-15 min) strengthening exercises (~20 min) balance activities (~20 min) cool-down (5-10 min) Balance training - OEP warm-up (10-15 min) strengthening exercises (~20 min) balance activities (~20 min) cool-down (5-10 min) IMT through POWERBREATHE 30 quick breaths twice daily at an adjustable resistance (equivalent to ~50% of [baseline] MIP). Will be increased up to 35 breaths as per patient's tolerance Sham IMT 60 slow breaths once daily at a load setting of 0 (corresponding to ~15% [baseline] MIP) training load adjustment will be prevented using sticky tape applied to the device's load adjuster.

Device: Inspiratory Muscle Training
Participants will perform home-based IMT twice daily [once in the morning (between 7:00 and 12:00 am) and once in the evening (between 16:00 and 21:00 pm)], for 8 consecutive weeks, using a mechanical pressure threshold loading device. In addition, participants in this group will try to increase the inspiratory resistance when the participants feel that 30 breaths are achievable with ease or if the paeticipants could reach 35 consecutive breaths.

Sham Comparator: Sham IMT

Standard exercise protocol according to ACSM's guidelines Standard exercise protocol according to ACSM's guidelines Balance training - OEP warm-up (10-15 min) strengthening exercises (~20 min) balance activities (~20 min) cool-down (5-10 min) Balance training - OEP warm-up (10-15 min) strengthening exercises (~20 min) balance activities (~20 min) cool-down (5-10 min) IMT through POWERBREATHE 30 quick breaths twice daily at an adjustable resistance (equivalent to ~50% of [baseline] MIP). Will be increased up to 35 breaths as per patient's tolerance Sham IMT 60 slow breaths once daily at a load setting of 0 (corresponding to ~15% [baseline] MIP) training load adjustment will be prevented using sticky tape applied to the device's load adjuster.

Device: Sham IMT
Participants will perform 60 slow breaths once daily at a load setting of 0 (corresponding to ~15% [baseline] MIP), using the same device as the IMT group. For the sham group, the ability to adjust the training load will be prevented using sticky tape applied to the device's load adjuster.

Outcome Measures

Primary Outcome Measures

  1. Fall risk score [After 6 months of intervention]

    Fall risk score will be calculated by Biodex Postural Stability system which is a highly reliable and objective measure for assessment of balance. It provides a 20o surface tilt in all 360 degree directions while providing an adjustable spring resistance to mobile surface from a static base of support at level 12 to a fully mobile base of support of level 1 same as wobble board like movements. Higher scores of fall risk score indicate greater balance deterioration and thus increase risk of fall. It would be assessed at baseline, after 12 weeks and after 6months of intervention.

  2. Overall stability index [After 6 months of intervention]

    Overall stability index will be calculated through Biodex Postural Stability system which is a highly reliable and objective measure for assessment of balance. It provides a 20o surface tilt in all 360 degree directions while providing an adjustable spring resistance to mobile surface from a static base of support at level 12 to a fully mobile base of support of level 1 same as wobble board like movements. It would be assessed at baseline, after 12 weeks and after 6months of intervention.

  3. Anterior / Posterior index [After 6 months of intervention]

    Anterior / Posterior index will be calculated through Biodex Postural Stability system which is a highly reliable and objective measure for assessment of balance. It provides a 20o surface tilt in all 360 degree directions while providing an adjustable spring resistance to mobile surface from a static base of support at level 12 to a fully mobile base of support of level 1 same as wobble board like movements. It would be assessed at baseline, after 12 weeks and after 6months of intervention.

  4. Medial / lateral index [After 6 months of intervention]

    Medial / lateral index will be calculated through Biodex Postural Stability system which is a highly reliable and objective measure for assessment of balance. It provides a 20o surface tilt in all 360 degree directions while providing an adjustable spring resistance to mobile surface from a static base of support at level 12 to a fully mobile base of support of level 1 same as wobble board like movements. It would be assessed at baseline, after 12 weeks and after 6months of intervention.

  5. Modified Clinical Test of Sensory Interaction in Balance (M - CTSIB) (composite score) [After 6 months of intervention]

    Modified Clinical Test of Sensory Interaction in Balance (M - CTSIB) will be calculated through Biodex Postural Stability system which is a highly reliable and objective measure for assessment of balance. It provides a 20o surface tilt in all 360 degree directions while providing an adjustable spring resistance to mobile surface from a static base of support at level 12 to a fully mobile base of support of level 1 same as wobble board like movements. It would be assessed at baseline, after 12 weeks and after 6months of intervention.

  6. Audit of Diabetes Dependent Quality of Life: [After 6 months of intervention]

    Audit of Diabetes Dependent Quality of Life (ADDQOL) is a reliable questionnaire used to measure individual's perception of the impact of diabetes on their quality of life. The scales range from -3 to +1 for 19 life domains (impact rating) and from 0 to +3 in attributed importance (importance rating). A weighted score for each domain is calculated as a multiplier of impact rating and importance rating (ranging from -9 to +3). Lower scores reflect poorer quality of life. It would be assessed ay baseline, after 12 weeks and after 6months of intervention.

Secondary Outcome Measures

  1. Peak expiratory flow rate (PEFR) [After 12 weeks of intervention]

    Peak expiratory flow rate (PEFR) measured through digital spirometer. Peak Expiratory Flow Rate (PEFR) measured through digital spirometer. Three zones of measurement are commonly used to interpret peak flow rates. Normal value of PEFR is (80-100%). Green zone indicates 80 to 100 percent of the usual or normal peak flow reading, yellow zone indicates 50 to 79 percent of the usual or normal peak flow readings, and red zone indicates less than 50 percent of the usual or normal peak flow readings. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  2. Forced vital capacity (FVC) [After 12 weeks of intervention]

    Forced vital capacity (FVC) measured through digital spirometer. If the value of FVC is within 80% of the reference value, the results are considered normal. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  3. Forced expiratory volume in 1sec (FEV1) [After 12 weeks of intervention]

    Forced expiratory volume in 1sec (FEV1) measured through digital spirometer. If the value of FEV1 is within 80% of the reference value, the results are considered normal. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  4. FVC/FEV1 [After 12 weeks of intervention]

    FVC/FEV1 measured through digital spirometer. The normal value for the FEV1/FVC ratio is 70% (and 65% in persons older than age 65). It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  5. Biering-Sørensen tests [After 12 weeks of intervention]

    Posterior trunk muscle endurance will be assessed using the Biering-Sørensen test, where participants will be asked to maintain a prone position, facing the floor, with their torso unsupported over the edge of the test bench. A strap will secure their legs and hips, and hands will be placed behind their head. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  6. Sit up test [After 12 weeks of intervention]

    Anterior trunk muscle endurance will be assessed using an isometric 'sit-up' task, by adopting a bent knee (~75°) sit-up. A strap will secure participants' feet, their arms will be folded across the chest, while their back will be placed against a support (60° angle from the testbed), and knees and hips will be flexed to 90 degree. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  7. Six Minute Walk test (6MWT) [After 12 weeks of intervention]

    Six Minute Walk test (6MWT) will be used to assess the functional capacity of the patients. The subjects will be instructed to walk for 6 minutes at a given time along a 30-m line at an interval of 1.5 m in an outdoor corridor, and the distance walked will be recorded in meters. The patients will be encouraged to continue walking as fast as possible. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

  8. 30sec sit-to-stand (30secSTS) [After 12 weeks of intervention]

    30sec sit-to-stand (30secSTS) is a test of physical performance which involves measuring the number of times participants can stand from a seated position, and then become seated again in 30 second period. ( Participants will be asked to sit on the edge of an armless chair (sitting height 46 cm, seat length 45 cm) with their arms folded across their chest. Participants will be instructed to rise, and then become seated as fast as possible, and as many times as possible in 30 seconds, with both feet maintaining contact with the floor at all time. It would be assessed at baseline, after 4th, 8th and 12th weeks of intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Mini Mental State Examination (MMSE) score >24

  • Type II diabetes: Post 5-8 years diagnosis

  • Berg Balance score (30-40)

  • Presence of polyneuropathy confirmed through Modified Toronto Clinical Scoring System.

Exclusion Criteria:
  • Patients on oxygen therapy

  • Uncontrolled diabetes (Confirmed through HbA1C) or disease exacerbation in last 3 months.

  • Patients practicing regular physical activity, any balance training in the last 6 months and previous or current experience with IMT

  • Patients with musculoskeletal comorbidities that may impair exercise performance

  • Peripheral oxygen saturation (SpO2) < 90% during the Six-Minute Walk Test (6MWT)

  • Patients with long COVID syndrome

  • Hypertensive subjects without control medication as well as those presenting with a hypertensive peak (> 140/90 mmHg) for more than 3 consecutive days

  • Patients with cardiorespiratory diseases or patients taking drugs that effect balance e.g., beta blockers, anti-anxiety and anti-depressant drugs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pakistan Railway Hospital, Riphah Rehabilitation Center Rawalpindi Punjab Pakistan 44000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Arshad Nawaz Malik, PhD, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT04947163
Other Study ID Numbers:
  • REC/13564 Suman Sheraz
First Posted:
Jul 1, 2021
Last Update Posted:
Oct 15, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 15, 2021